Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other 3Gynecologic 1

Conditions

Obesity 3Prostatic Neoplasms 2Polycystic Ovary Syndrome 2Pancreatic Neoplasms 1Overweight 1Neoplasms 1Metabolic Syndrome 1Inflammation 1Gastrointestinal Neoplasms 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Dyslipidemias 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Tirzepatide 9Exercise 5Counseling 4semaglutide 3Resistance Training 3Methods 3Standard of Care 2Progestins 2Nutrition Assessment 2Megestrol Acetate 2Diet Therapy 2mirabegron 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1atezolizumab 1Weights and Measures 1Walk Test 1Vitamin D 1Urine Specimen Collection 1Trehalase 1Topiramate 1Therapeutics 1Tablets 1TIC10 compound 1Surveys and Questionnaires 1Stents 1Spermine Synthase 1Specimen Handling 1Sampling Studies 1Qsymia 1Psychology, Positive 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Obesity × semaglutide × 1 year × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

NCT05756764 2025-09-09

Anti-obesity Pharmacotherapy and Inflammation

Louisiana State University Health Sciences Center in New Orleans

Active not recruiting
30 enrolled
Other

Inflammation, Obesity, Metabolic Syndrome, Dyslipidemias

NCT05819853 2025-08-28

RESTORE

University of Colorado, Denver

Phase 3 Recruiting
80 enrolled
Other

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡